Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,145.50    6.50 (0.57%)
Bid:
1,145.00
Ask:
1,146.00
Spread: 1.00 (0.087%)
Market Cap: £9.72b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Block listing Interim Review

16 Oct 2025 10:10

RNS Number : 6755D
Smith & Nephew Plc
16 October 2025
 

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

 

Name of applicant:

Smith & Nephew plc

Name of scheme:

Global Share Plan 2010

Period of return:

From:

1 February 2025

To:

31 July 2025

Balance of unallotted securities under scheme(s) from previous return:

3,962

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

-

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

206

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

3,756

 

Name of applicant:

Smith & Nephew plc

Name of scheme:

Smith & Nephew ShareSave Plan (2012)

Period of return:

From:

1 February 2025

To:

31 July 2025

Balance of unallotted securities under scheme(s) from previous return:

432,252

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

-

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

-

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

432,252

 

Name of applicant:

Smith & Nephew plc

Name of scheme:

Smith & Nephew International ShareSave Plan (2012)

Period of return:

From:

1 February 2025

To:

31 July 2025

Balance of unallotted securities under scheme(s) from previous return:

612,504

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

-

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

-

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

612,504

 

Name of applicant:

Smith & Nephew plc

Name of scheme:

Global Share Plan 2020

Period of return:

From:

1 February 2025

To:

31 July 2025

Balance of unallotted securities under scheme(s) from previous return:

409,016

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

-

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

5,758

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

 403,258

 

Name of applicant:

Smith & Nephew plc

Name of scheme:

Smith & Nephew ShareSave Plan (2022)

Period of return:

From:

1 February 2025

To:

31 July 2025

Balance of unallotted securities under scheme(s) from previous return:

126,126

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

-

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

-

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

126,126

 

Name of applicant:

Smith & Nephew plc

Name of scheme:

Smith & Nephew International ShareSave Plan (2022)

Period of return:

From:

1 February 2025

To:

31 July 2025

Balance of unallotted securities under scheme(s) from previous return:

35,210

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

-

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

-

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

35,210

 

Name of contact:

Philip Horner, Deputy Company Secretary

Telephone number of contact:

01923 477100

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRGCBDGXGBDGUL
Date   Source Headline
11th May 20212:32 pmRNSHolding(s) in Company
4th May 202112:38 pmRNSTotal Voting Rights
4th May 20219:45 amRNSDirector/PDMR Shareholding
29th Apr 20217:00 amRNSTrading Statement
28th Apr 20217:00 amRNSDividend Declaration
14th Apr 20216:04 pmRNSResult of AGM
1st Apr 20211:15 pmRNSTotal Voting Rights
1st Apr 20219:00 amRNSDirector Declaration
31st Mar 202110:00 amRNSAdditional Annual General Meeting update
19th Mar 20211:00 pmRNSDirector/PDMR Shareholding
19th Mar 20219:00 amRNSNotice of Results
17th Mar 20213:30 pmRNSDirector/PDMR Shareholding
10th Mar 20215:45 pmRNSDirector/PDMR Shareholding
9th Mar 20215:48 pmRNSDirector/PDMR Shareholding
8th Mar 202111:30 amRNSDirector/PDMR Shareholding
1st Mar 20214:18 pmRNSAnnual Financial Report
1st Mar 20211:00 pmRNSTotal Voting Rights
18th Feb 20217:00 amRNSFourth Quarter and Full Year 2020 Results
11th Feb 20217:00 amRNSDirector Declaration
10th Feb 20217:00 amRNSJohn Ma joins Smith+Nephew's Board as NED
3rd Feb 20215:00 pmRNSDirector/PDMR Shareholding
1st Feb 20211:41 pmRNSBlock listing Interim Review
1st Feb 202112:30 pmRNSTotal Voting Rights
29th Jan 20217:00 amRNSNotice of Results
28th Jan 20219:15 amRNSDirector Declaration
14th Jan 202111:30 amRNSDirector/PDMR Shareholding
11th Jan 20217:00 amRNSTrading Statement
6th Jan 20211:00 pmRNSDirectorate Change
4th Jan 20215:46 pmRNSSmith+Nephew Completes Orthopaedics Acquisition
4th Jan 202111:00 amRNSTotal Voting Rights
22nd Dec 20209:00 amRNSDirector/PDMR Shareholding
1st Dec 202012:40 pmRNSTotal Voting Rights
24th Nov 20203:30 pmRNSDirector/PDMR Shareholding
16th Nov 20203:30 pmRNSDirector/PDMR Shareholding
10th Nov 20207:00 amRNSDirector/PDMR Shareholding
10th Nov 20207:00 amRNSTotal Voting Rights
3rd Nov 202010:00 amRNSDirector/PDMR Shareholding
2nd Nov 20205:04 pmRNSDirector/PDMR Shareholding
2nd Nov 20202:45 pmRNSTotal Voting Rights
29th Oct 20203:05 pmRNSDirector/PDMR Shareholding
29th Oct 20207:00 amRNSTrading Statement
20th Oct 202010:00 amRNSKatarzyna Mazur-Hofsaess joins Smith+Nephew as NED
15th Oct 202011:52 amRNSDividend Declaration
9th Oct 20209:08 amRNSNotice of Results
8th Oct 20207:00 amRNSSmith+Nephew Prices USD Bond Issue
1st Oct 202011:08 amRNSTotal Voting Rights
1st Oct 20207:00 amRNSTrading Statement
29th Sep 20201:04 pmRNSExtremities Acquisition
15th Sep 20204:56 pmRNSDirector/PDMR Shareholding
10th Sep 202010:26 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.